AEON Stock Summary and Trading Ideas (Aeon Biopharma Class A | AMEX:AEON)

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Aeon Biopharma Class A trades on the AMEX stock market under the symbol AEON.

As of January 2, 2025, AEON stock price climbed to $0.55 with 64,000 million shares trading.

AEON has a beta of 2.03, meaning it tends to be more sensitive to market movements. AEON has a correlation of 0.02 to the broad based SPY ETF.

AEON has a market cap of $21.98 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that AEON belongs to (by Net Assets): VTI, VXF, IWC.

AEON has underperformed the market in the last year with a price return of -92.4% while the SPY ETF gained +24.5%. AEON has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -47.6% and -15.4%, respectively, while the SPY returned +2.2% and -2.9%, respectively.

AEON support price is $.48 and resistance is $.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AEON shares will trade within this expected range on the day.